Figure 1From: MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2Growth curves for Kelly (A) and SK-N-AS (B) following transfection with the anti-miR-184 (×3 biological replicates). A scrambled anti-miR was used as negative control.Back to article page